Epidemiological Study of the Prevalence of Age-Related Macular Degeneration in Portugal

January 4, 2017 updated by: Association for Innovation and Biomedical Research on Light and Image
This is an epidemiological study to assess the the prevalence of Age-Related Macular (ARM) Degeneration in Portugal.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

6023

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Portugal
      • Mira, Portugal
        • ARS Centro - Centro de Saúde de Mira
    • Coimbra
      • Lousã, Coimbra, Portugal, 3200-201
        • Health care units of Lousã and Trevim-Sol

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

55 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Participants with 55 or more years-old

Description

Inclusion Criteria:

  • Participants with 55 years-old

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
ARM
Time Frame: 1 month after the screening
Signs of Age-Related Macular Degeneration
1 month after the screening

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Other ocular disease
Time Frame: 1 month after screening
Signs of other ocular disease such as: diabetic retinopathy, glaucoma, cataract, etc.
1 month after screening

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Association for Innovation and Biomedical Research on Light and Image

Investigators

  • Study Director: José Cunha-Vaz, MD, PhD, Association for Innovation and Biomedical Research on Light and Image
  • Principal Investigator: Rufino Silva, MD, PhD, Association for Innovation and Biomedical Research on Light and Image

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2009

Primary Completion (Actual)

October 1, 2013

Study Completion (Actual)

October 1, 2013

Study Registration Dates

First Submitted

February 15, 2011

First Submitted That Met QC Criteria

February 17, 2011

First Posted (Estimate)

February 18, 2011

Study Record Updates

Last Update Posted (Estimate)

January 5, 2017

Last Update Submitted That Met QC Criteria

January 4, 2017

Last Verified

January 1, 2017

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CC-01-2009

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Age-Related Macular Degeneration

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Dominican Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe